Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 58 | 101 | 56 | 32 |
| Cost of Goods | 23 | 38 | 19 | 17 |
| Gross Profit | 36 | 63 | 37 | 15 |
| Operating Expenses | -80 | 313 | 199 | 485 |
| Operating Income | 137 | -212 | -143 | -453 |
| Interest Expense | 2 | 2 | 2 | 2 |
| Other Income | 0 | 0 | -18 | 0 |
| Pre-tax Income | 135 | -214 | -163 | -455 |
| Net Income Continuous | 135 | -214 | -163 | -455 |
| Net Income | $135 | $-214 | $-163 | $-455 |
| EPS Basic Total Ops | 0.01 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | 0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Total Ops | 0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | 0.01 | -0.01 | -0.01 | -0.02 |
| EBITDA(a) | $142 | $-207 | $-137 | $-442 |